Strobeck Mark

Insider profile

Strobeck Mark's trades of Zyla Life Sciences's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2017-10-03 2017-10-02 PlS Planned sale
78,082 +22.4%
113.69
US$3,368,332
78,082 +22.4% 113.69 US$3,368,332
2017-07-05 2017-06-30 PlS Planned sale
16,149 +5.0%
374.92
US$1,681,772
16,149 +5.0% 374.92 US$1,681,772
2017-01-04 2016-12-30 PlS Planned sale
61,170 +39.5%
331.32
US$2,336,111
61,170 +39.5% 331.32 US$2,336,111
2016-10-03 2016-09-30 PlS Planned sale
8,700 -10.8%
7.55
US$65,685
8,700 -10.8% 7.55 US$65,685
2016-07-05 2016-06-30 PlS Planned sale
8,700 -9.7%
4.68
US$40,716
8,700 -9.7% 4.68 US$40,716
2016-01-05 2015-12-31 PlS Planned sale
8,700 -8.2%
10.40
US$90,480
8,700 -8.2% 10.40 US$90,480